These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15195244)

  • 1. Analysis of immune activation and clinical events in acute infectious mononucleosis.
    Williams H; Macsween K; McAulay K; Higgins C; Harrison N; Swerdlow A; Britton K; Crawford D
    J Infect Dis; 2004 Jul; 190(1):63-71. PubMed ID: 15195244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4).
    Romero X; Benítez D; March S; Vilella R; Miralpeix M; Engel P
    Tissue Antigens; 2004 Aug; 64(2):132-44. PubMed ID: 15245368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4.
    Sayós J; Nguyen KB; Wu C; Stepp SE; Howie D; Schatzle JD; Kumar V; Biron CA; Terhorst C
    Int Immunol; 2000 Dec; 12(12):1749-57. PubMed ID: 11099315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors.
    Chen R; Relouzat F; Roncagalli R; Aoukaty A; Tan R; Latour S; Veillette A
    Mol Cell Biol; 2004 Jun; 24(12):5144-56. PubMed ID: 15169881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family.
    Fraser CC; Howie D; Morra M; Qiu Y; Murphy C; Shen Q; Gutierrez-Ramos JC; Coyle A; Kingsbury GA; Terhorst C
    Immunogenetics; 2002 Feb; 53(10-11):843-50. PubMed ID: 11862385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a new disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease.
    Erdõs M; Uzvölgyi E; Nemes Z; Török O; Rákóczi E; Went-Sümegi N; Sümegi J; Maródi L
    Hum Mutat; 2005 May; 25(5):506. PubMed ID: 15841490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease.
    Nichols KE; Ma CS; Cannons JL; Schwartzberg PL; Tangye SG
    Immunol Rev; 2005 Feb; 203():180-99. PubMed ID: 15661030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.
    Lewis J; Eiben LJ; Nelson DL; Cohen JI; Nichols KE; Ochs HD; Notarangelo LD; Duckett CS
    Clin Immunol; 2001 Jul; 100(1):15-23. PubMed ID: 11414741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of CD244 and SAP regulated CD8 T cell responses of patients with HTLV-I associated neurologic disease.
    Enose-Akahata Y; Matsuura E; Oh U; Jacobson S
    PLoS Pathog; 2009 Dec; 5(12):e1000682. PubMed ID: 19997502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD150 is a member of a family of genes that encode glycoproteins on the surface of hematopoietic cells.
    Wang N; Morra M; Wu C; Gullo C; Howie D; Coyle T; Engel P; Terhorst C
    Immunogenetics; 2001 Jul; 53(5):382-94. PubMed ID: 11486275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAP couples Fyn to SLAM immune receptors.
    Chan B; Lanyi A; Song HK; Griesbach J; Simarro-Grande M; Poy F; Howie D; Sumegi J; Terhorst C; Eck MJ
    Nat Cell Biol; 2003 Feb; 5(2):155-60. PubMed ID: 12545174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic redistribution of the activating 2B4/SAP complex at the cytotoxic NK cell immune synapse.
    Roda-Navarro P; Mittelbrunn M; Ortega M; Howie D; Terhorst C; Sánchez-Madrid F; Fernández-Ruiz E
    J Immunol; 2004 Sep; 173(6):3640-6. PubMed ID: 15356108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling lymphocytic activation molecule (SLAM) regulates T cellular cytotoxicity.
    Henning G; Kraft MS; Derfuss T; Pirzer R; de Saint-Basile G; Aversa G; Fleckenstein B; Meinl E
    Eur J Immunol; 2001 Sep; 31(9):2741-50. PubMed ID: 11536173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling lymphocyte activation molecule-associated protein is a negative regulator of the CD8 T cell response in mice.
    Chen G; Tai AK; Lin M; Chang F; Terhorst C; Huber BT
    J Immunol; 2005 Aug; 175(4):2212-8. PubMed ID: 16081788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice.
    Graham DB; Bell MP; McCausland MM; Huntoon CJ; van Deursen J; Faubion WA; Crotty S; McKean DJ
    J Immunol; 2006 Jan; 176(1):291-300. PubMed ID: 16365421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production.
    Aversa G; Chang CC; Carballido JM; Cocks BG; de Vries JE
    J Immunol; 1997 May; 158(9):4036-44. PubMed ID: 9126961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells.
    Castro AG; Hauser TM; Cocks BG; Abrams J; Zurawski S; Churakova T; Zonin F; Robinson D; Tangye SG; Aversa G; Nichols KE; de Vries JE; Lanier LL; O'Garra A
    J Immunol; 1999 Dec; 163(11):5860-70. PubMed ID: 10570270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of signaling lymphocytic activation molecule-associated protein interrupts IFN-gamma production in human tuberculosis.
    Pasquinelli V; Quiroga MF; Martínez GJ; Zorrilla LC; Musella RM; Bracco MM; Belmonte L; Malbrán A; Fainboim L; Sieling PA; García VE
    J Immunol; 2004 Jan; 172(2):1177-85. PubMed ID: 14707094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of anti-tumor activity in vitro and in vivo by CD150 and SAP.
    Mehrle S; Schmidt J; Büchler MW; Watzl C; Märten A
    Mol Immunol; 2008 Feb; 45(3):796-804. PubMed ID: 17692919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of signaling lymphocytic activation molecule triggers a signaling cascade that enhances Th1 responses in human intracellular infection.
    Quiroga MF; Martínez GJ; Pasquinelli V; Costas MA; Bracco MM; Malbrán A; Olivares LM; Sieling PA; García VE
    J Immunol; 2004 Sep; 173(6):4120-9. PubMed ID: 15356162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.